Xtrackers MSCI World Health Care UCITS ETF 1c
The Xtrackers MSCI World Health Care UCITS ETF 1c is an exchange-traded index fund (ETF) from Xtrackers that tracks the MSCI World Health Care index physically. Income is distributed to investors; it trades as a Europe-domiciled UCITS fund. The fund spreads across 111 individual holdings – the largest currently Eli Lilly at 12.12%. The full composition plus the sector and country breakdown are shown below; it is one of 104 ETFs we cover.
The ten largest holdings make up 48.9% of the fund, out of 111 in total. The largest sector is Pharmaceuticals at 46.6% (as of Nov 2, 2026).
Alysly Data Analysis: XDWH
Data Points
The map shows how XDWH connects to ETFs, indices and other names. Each link is based on measured data and is not a recommendation.
- Amgen Stock · holds
- Bristol-Myers Squibb Company Stock · holds
- Gilead Sciences Stock · holds
- Glaxosmithkline Stock · holds
- Johnson & Johnson Stock · holds
- Novartis Stock · holds
- Roche Holding Ltd Stock · holds
- Vertex Pharmaceuticals Incorporated Stock · holds
- SPYE ETF · overlaps with
- MSCI World Health Care Index · tracks
The 100 Largest Holdings
of 111 in total · as of Nov 2, 2026
Top Sectors
Geographic Breakdown
Holdings lists from our database since Sep 30, 2026, 3 reporting dates.
Changes in Holdings
This compares the holdings list of Sep 30, 2026 with that of Nov 2, 2026: 9 names were added and 11 dropped out. Weights also shift without any buying or selling, because the prices of the holdings move differently.
Added
- Eli Lilly and Co · 12.12%
- Novo Nordisk A/S · 1.38%
- Becton Dickinson and Co · 0.60%
- Veeva Systems Inc · 0.50%
- Mettler-Toledo International Inc · 0.38%
Removed
- Eli Lilly · 11.15%
- Roche PS Par AG · 3.53%
- Novo Nordisk Class B · 1.45%
- Becton Dickinson · 0.59%
- Veeva Systems Class A · 0.48%
Weight Up
- Roche Holding AG · 3.92% (+3.77 pp)
- AbbVie Inc · 5.67% (+0.13 pp)
- Genmab · 0.37% (+0.13 pp)
- Amgen Inc · 2.74% (+0.09 pp)
- Novartis AG · 3.23% (+0.09 pp)
Weight Down
- Johnson & Johnson · 7.30% (-0.39 pp)
- Merck & Co Inc · 3.98% (-0.33 pp)
- Bristol-Myers Squibb Co · 1.38% (-0.15 pp)
- Alnylam Pharmaceuticals Inc · 0.26% (-0.14 pp)
- Glaxosmithkline · 1.08% (-0.09 pp)
Compared With Other Funds
How much this fund overlaps with others — the figure is the share of capital financing the same companies in both.
Data and Charts: XDWH
Effective means the number of equally weighted holdings that would produce the same spread as this fund's 111 counted positions.
Key Facts
| Distribution | |
|---|---|
| Product structure |
NAV History
The chart shows net asset value per share and is set to the current year by default. The NAV is up 15.6% year to date and up 23.9% over twelve months. The last recorded close on October 30, 2026, was at 100% of the 52-week range.
Net asset value per share in USD, set once per trading day. It is not an exchange price. Distributions are not added back, so for distributing funds the value drops by the amount paid out on the distribution date.
Net asset values from our database since Nov 22, 2010, 4,018 daily values.
Performance
Calculated from the fund's NAV history.
| Trailing (1Y) | +23.9% | Year to date | +15.6% |
|---|---|---|---|
| Calendar year 2011 | +9.0% | ||
| Calendar year 2012 | +17.1% | ||
| Calendar year 2013 | +35.9% | ||
| Calendar year 2014 | +17.7% | ||
| Calendar year 2015 | +6.2% | ||
| Calendar year 2016 | -5.3% | ||
| Calendar year 2017 | +20.1% | ||
| Calendar year 2018 | +1.1% | ||
| Calendar year 2019 | +24.4% | ||
| Calendar year 2020 | +13.3% | ||
| Calendar year 2021 | +19.7% | ||
| Calendar year 2022 | -5.4% | ||
| Calendar year 2023 | +3.7% | ||
| Calendar year 2024 | +1.1% | ||
| Calendar year 2025 | +14.8% |
Fundamental Analysis: XDWH
Tax (Germany)
Equity ETF: 30% partial exemption (Teilfreistellung). Distributing → Vorabpauschale barely relevant. Details.
Alternative ETFs on the Same Index
- State Street® SPDR® MSCI World Health Care UCITS ETF · TER 0.30% · 804 M